Famotidine Injection
NDC Package 0641-6021-10
Package Information
Famotidine injection is famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. This formulation utilizes a injection delivery system. Marketed by Hikma Pharmaceuticals Usa Inc., this product is identified by NDC 0641-6021 and is authorized under FDA application ANDA075488.
Identification & Billing
- RxCUI: 1743833 - famotidine 20 MG in 2 ML Injection
- RxCUI: 1743833 - 2 ML famotidine 10 MG/ML Injection
- RxCUI: 1743833 - famotidine 20 MG per 2 ML Injection
- RxCUI: 204441 - famotidine 10 MG/ML Injectable Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0641 - Hikma Pharmaceuticals Usa Inc.
- 0641-6021 - Famotidine
- 0641-6021-10 - 10 VIAL in 1 CARTON / 20 mL in 1 VIAL (0641-6021-01)
- 0641-6021 - Famotidine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0641-6021-10 identifies a specific commercial package of 10 vial in 1 carton / 20 ml in 1 vial (0641-6021-01) of Famotidine, a human prescription drug labeled by Hikma Pharmaceuticals Usa Inc.. This injection is formulated for intravenous use and contains famotidine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hikma Pharmaceuticals Usa Inc. on April 16, 2001. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist.
How is this Hikma Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00641602110. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.